Camance, Aidelyn C.
HRN: 29-27-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/12/2026
07/12/2026
IV
750mg
Now As LD
CAP HR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes